Evidence map›Paper›PMID 32661293›Full record

Trial reportScientific reports2020

Competitiveness and individual characteristics: a double-blind placebo-controlled study using oxytocin.

Hirofumi Kurokawa, Yusuke Kinari, Hiroko Okudaira, Kiyotaka Tsubouchi, Yoshimichi Sai, Mitsuru Kikuchi, Haruhiro Higashida, Fumio Ohtake

Open access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Hirofumi KurokawaSchool of Economics and Management, University of Hyogo, 8-2-1 Gakuen-nishi-machi, Nishi-ku, Kobe, Hyogo, 651-2197, Japan. kurokawa@em.u-hyogo.ac.jp.
Yusuke KinariHirao School of Management, Konan University, Nishinomiya, Hyogo, Japan.
Hiroko OkudairaDoshisha Business School, Doshisha University, Kyoto, Kyoto, Japan.
Kiyotaka TsubouchiDepartment of Biophysical Genetics, Research Center for Child Mental Development, Kanazawa University, Kanazawa, Japan.
Yoshimichi SaiDepartment of Biophysical Genetics, Research Center for Child Mental Development, Kanazawa University, Kanazawa, Japan.
Mitsuru KikuchiDepartment of Biophysical Genetics, Research Center for Child Mental Development, Kanazawa University, Kanazawa, Japan.
Haruhiro HigashidaDepartment of Biophysical Genetics, Research Center for Child Mental Development, Kanazawa University, Kanazawa, Japan.
Fumio OhtakeDepartment of Economics, Osaka University, Toyonaka, Osaka, Japan.
Kanazawa University · JPDoshisha University · JPKonan University · JPOsaka University of Economics · JPUniversity of Hyogo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxytocin-enhanced prosocial behaviour depends on individual characteristics. This study investigated the relationship between oxytocin and competitiveness, which is another important social trait and predicts economic and social outcomes. In this double-blind, randomized, and placebo-controlled study of 192 male participants, we examined whether oxytocin moderates competitiveness and whether the effect of oxytocin on competitiveness is amplified in individuals with autistic traits. While our results show no relationship between oxytocin and competitiveness, we observed suggestive patterns: albeit not significantly, oxytocin reduced and enhanced competitiveness among participants without autistic traits and among their counterparts with autistic traits, respectively.

Indexed as

Autistic DisorderCompetitive BehaviorOxytocinSocial BehaviorAdultDouble-Blind MethodHumansMaleYoung AdultOxytocin

Identifiers

PMID32661293
PMCPMC7359354
OpenAlexW3041187694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.